Psychemedics Corporation
PMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $20 | $22 | $25 | $25 |
| % Growth | -10.9% | -12.4% | 1.3% | – |
| Cost of Goods Sold | $13 | $14 | $16 | $15 |
| Gross Profit | $7 | $8 | $9 | $10 |
| % Margin | 36.1% | 38.1% | 36.8% | 41.2% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $6 | $7 | $6 | $6 |
| SG&A Expenses | $8 | $10 | $9 | $9 |
| Sales & Mktg Exp. | $3 | $3 | $3 | $3 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9 | $11 | $10 | $10 |
| Operating Income | -$2 | -$3 | -$1 | -$3 |
| % Margin | -9.6% | -13.2% | -4.3% | -14% |
| Other Income/Exp. Net | -$0 | -$1 | $0 | -$1 |
| Pre-Tax Income | -$2 | -$3 | -$1 | -$1 |
| Tax Expense | -$0 | $1 | $0 | -$0 |
| Net Income | -$2 | -$4 | -$1 | -$1 |
| % Margin | -9.5% | -18.8% | -4.3% | -2.7% |
| EPS | -0.32 | -0.72 | -0.19 | -0.12 |
| % Growth | 55.6% | -278.9% | -58.3% | – |
| EPS Diluted | -0.32 | -0.72 | -0.19 | -0.12 |
| Weighted Avg Shares Out | 6 | 6 | 6 | 6 |
| Weighted Avg Shares Out Dil | 6 | 6 | 6 | 6 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $3 | $3 | $4 |
| EBITDA | $0 | -$1 | $2 | $4 |
| % Margin | 1% | -3.4% | 8.8% | 15.7% |